US Patent Issued to Bristol-Myers Squibb on July 1 for "System for verifying accuracy of serially-connected drug modules in a combinatorial drug delivery device" (New Jersey Inventor)

ALEXANDRIA, Va., July 3 -- United States Patent no. 12,343,498, issued on July 1, was assigned to Bristol-Myers Squibb Co. (Princeton, N.J.).

"System for verifying accuracy of serially-connected drug modules in a combinatorial drug delivery device" was invented by Martin John McLoughlin (Hillsborough, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "In one aspect, a system is provided of verifying the accuracy of a plurality of serially-connected drug modules of a combinatorial drug delivery device, each of the drug modules including a drug reservoir, the system including: a machine-readable code located on each of the drug modules; application software configured to generate an activation code based on t...